Glenview Trust’s Equifax EFX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,050
Closed -$228K 508
2025
Q4
$228K Buy
1,050
+14
+1% +$3.07K ﹤0.01% 462
2025
Q3
$266K Sell
1,036
-2
-0.2% -$503 ﹤0.01% 447
2025
Q2
$269K Buy
1,038
+2
+0.2% +$509 ﹤0.01% 446
2025
Q1
$252K Sell
1,036
-8
-0.8% -$2.01K ﹤0.01% 434
2024
Q4
$266K Buy
1,044
+8
+0.8% +$2.14K 0.01% 433
2024
Q3
$304K Buy
1,036
+31
+3% +$8.74K 0.01% 409
2024
Q2
$244K Hold
1,005
﹤0.01% 425
2024
Q1
$269K Hold
1,005
0.01% 415
2023
Q4
$249K Buy
+1,005
New +$204K 0.01% 426
2023
Q3
Sell
-1,005
Closed -$236K 452
2023
Q2
$236K Buy
1,005
+5
+0.5% +$1.05K 0.01% 423
2023
Q1
$203K Buy
+1,000
New +$208K 0.01% 435
2022
Q2
Sell
-1,000
Closed -$237K 412
2022
Q1
$237K Hold
1,000
0.01% 391
2021
Q4
$293K Hold
1,000
0.01% 367
2021
Q3
$253K Hold
1,000
0.01% 363
2021
Q2
$240K Buy
+1,000
New +$223K 0.01% 375

Other funds holding EFX

Glenview Trust's EFX Position: Q1 2026 in Review

Glenview Trust sold out of Equifax (EFX) in Q1 2026, closing a stake of 1,050 shares — an estimated $228K sold.

Glenview Trust first reported a position in EFX in Q2 2021 and held it in 15 quarters. The position peaked at $304K in Q3 2024. 870 funds tracked by Wall St. Rank hold EFX as of Q1 2026.

  • Glenview Trust reported no remaining Equifax position as of Q1 2026 after selling out during the quarter.
  • Glenview Trust sold 1,050 Equifax shares in Q1 2026, an estimated $228K.
  • Glenview Trust first reported a position in Equifax in Q2 2021 and held it in 15 quarters.
  • Glenview Trust's Equifax position peaked at $304K in Q3 2024.
  • 870 funds tracked by Wall St. Rank held Equifax as of Q1 2026.

Based on Glenview Trust's 13F filing for Q1 2026, filed 8 May 2026.